Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
2006 1
2014 1
2015 1
2016 4
2017 8
2018 5
2019 8
2020 12
2021 8
2022 8
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
A phase II study of lenalidomide and rituximab (R2) combination in patients with high-risk refractory/relapsed diffuse large B-cell lymphoma.
Noel R, Zemmour C, Montes de Oca C, Belmecheri N, Aurran-Schleinitz T, Coso D, Lopez Almeida L, Mescam L, Vey N, Bladé JS, Slama B, Bouabdallah R, Schiano de Colella JM. Noel R, et al. Among authors: zemmour c. Hematology. 2023 Dec;28(1):2207948. doi: 10.1080/16078454.2023.2207948. Hematology. 2023. PMID: 37133334 Clinical Trial.
Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in adult cancers: data mining of 1385 electronic patient records.
Beaufils M, Amodru V, Tejeda M, Boher JM, Zemmour C, Chanez B, Chrétien AS, Gorvel L, Gravis G, Bruyat D, Mari R, Madroszyk A, Cuny T, Gonçalves A, Lisberg AE, Olive D, Tassy L, Castinetti F, Rochigneux P. Beaufils M, et al. Among authors: zemmour c. J Immunother Cancer. 2023 Aug;11(8):e006786. doi: 10.1136/jitc-2023-006786. J Immunother Cancer. 2023. PMID: 37536938 Free PMC article.
Low dose amiodarone reduces tumor growth and angiogenesis.
Steinberg E, Fluksman A, Zemmour C, Tischenko K, Karsch-Bluman A, Brill-Karniely Y, Birsner AE, D'Amato RJ, Benny O. Steinberg E, et al. Among authors: zemmour c. Sci Rep. 2020 Oct 22;10(1):18034. doi: 10.1038/s41598-020-75142-1. Sci Rep. 2020. PMID: 33093573 Free PMC article.
JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid Leukemia.
De Grandis M, Bardin F, Fauriat C, Zemmour C, El-Kaoutari A, Sergé A, Granjeaud S, Pouyet L, Montersino C, Chretien AS, Mozziconacci MJ, Castellano R, Bidaut G, Boher JM, Collette Y, Mancini SJC, Vey N, Aurrand-Lions M. De Grandis M, et al. Among authors: zemmour c. Cancer Res. 2017 Dec 1;77(23):6627-6640. doi: 10.1158/0008-5472.CAN-17-1223. Epub 2017 Sep 28. Cancer Res. 2017. PMID: 28972073
Prediction of early discharge after gynaecological oncology surgery within ERAS.
Lambaudie E, Mathis J, Zemmour C, Jauffret-Fara C, Mikhael ET, Pouliquen C, Sabatier R, Brun C, Faucher M, Mokart D, Houvenaeghel G. Lambaudie E, et al. Among authors: zemmour c. Surg Endosc. 2020 May;34(5):1985-1993. doi: 10.1007/s00464-019-06974-w. Epub 2019 Jul 15. Surg Endosc. 2020. PMID: 31309314
High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancers.
Varela Cagetti L, Zemmour C, Salem N, Minsat M, Ferrè M, Mailleux H, Giovaninni M, Lelong B, De Chaisemartin C, Ries P, Poizat F, Tallet A, Moureau-Zabotto L. Varela Cagetti L, et al. Among authors: zemmour c. Brachytherapy. 2019 Nov-Dec;18(6):814-822. doi: 10.1016/j.brachy.2019.08.005. Epub 2019 Sep 9. Brachytherapy. 2019. PMID: 31515067
57 results